ISR Immune System Regulation AB
0
0
+€0.00+0% 00:00 Today
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
ISR Immune System Regulation Holding AB (publ) researches and develops drugs for the treatment of viral infections in Sweden. The company's product pipeline includes Covid-19 vaccine, HBV, HIV, and oncology. The company is headquartered in Stockholm, Sweden.
Show More
CEO
Prof. Ola S. Winqvist M.D., Ph.D.
Employees
6
Country
Sweden
ISIN
SE0008212195
WKN
000A2AGDK
Listings
0 Comments
Share your thoughts
FAQs
What is ISR Immune System Regulation AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange ISR Immune System Regulation AB stocks are traded under the ticker 5JK.MU.
How many employees does ISR Immune System Regulation AB have?▼
As of November 2, 2026, the company has 6 employees.
In which sector is ISR Immune System Regulation AB located?▼
ISR Immune System Regulation AB operates in the Health & Wellness sector.
When did ISR Immune System Regulation AB complete a stock split?▼
ISR Immune System Regulation AB has not had any recent stock splits.
Where is ISR Immune System Regulation AB headquartered?▼
ISR Immune System Regulation AB is headquartered in Stockholm, Sweden.